Você procurou por: neuraminidase (Inglês - Maltês)

neuraminidase inhibitor
inibitur tan-newraminidażi

influenza virus surface antigens (haemagglutinin and neuraminidase)* of strain:
antiġeni tal- wiċċ tal- virus ta 'l- influwenza (haemagglutinin u neuraminidase) * tar- razza:

pharmacotherapeutic group: antivirals for systemic use, neuraminidase inhibitors atc code: j05ah02
kategorija farmakoterapewtika: antivirali għall-użu sistemiku, inibituri ta’ neuraminidase, kodiċi atc: j05ah02

ebilfumin contains oseltamivir, which belongs to a group of medicines named neuraminidase inhibitors.
ebilfumin fih oseltamivir, li jagħmel parti minn grupp ta' mediċini msejħa inibituri ta’ neuraminidase.

since neuraminidase activity is extracellular, oseltamivir carboxylate distributes to all sites of influenza virus spread.
billi l- attività ta ’ neuraminidase hija estraċellulari, oseltamivir carboxylate jitqassam fil- postijiet kollha fejn jinfirex il - virus ta 'l- influwenza.

the active ingredients of the vaccine are purified viral proteins (called haemagglutinin and neuraminidase).
l-ingredjenti attivi tat-tilqima huma proteini virali ppurifikati (imsejħa haemagglutinin u eraminidase).

a final product batch test should be introduced to identify the neuraminidase component and confirm that the vaccine has the correct composition.
għandu jiġi ntrodott test tal- lott finali tal- prodott sabiex jidentifika il - komponent nuraminidejs u jikkonferma li l- vaċċin għandu l- kompożizzjoni korretta.

influenza virus surface antigens (haemagglutinin and neuraminidase)*, inactivated, of the following strains:
antiġeni tal-wiċċ tal-virus ta’ l-influwenza (haemagglutinin u neuraminidase)*, inattivati, tar-razez li ġejjin:

test for identification: a final product batch test should be introduced to identify the neuraminidase component and confirm that the vaccine has the correct composition.
test għal identifikazzjoni: għandu jiġi ntrodott test tal-lott finali tal-prodott sabiex jidentifika il- komponent nuraminidejs u jikkonferma li l-vaċċin għandu l-kompożizzjoni korretta.

neuraminidase enzyme ic50 values for oseltamivir for clinically isolated influenza a ranged from 0.1 nm to 1.3 nm, and for influenza b was 2.6 nm.
23 il- valuri ta 'l- enżima neuraminidase ic50 meta ngħata oseltamivir, għall- influwenza a iżolata klinikament varjaw minn 0. 1 nm sa 1. 3 nm, u għall- influwenza b kienu 2. 6 nm.

if the circulating avian influenza field virus has a different n component to the n1 included in the vaccine, it may be possible to differentiate between vaccinated from infected birds by using a diagnostic test to detect neuraminidase antibodies.
jekk il-vajrus ta’ l-influwenza avjarju li jiċċirkola għandu komponent n differenti mill-n1li jinsab fil-vaċċin, jista’ jkun possibbli li wieħed jagħmel differenza bejn vaċċin minn għasfur infettat u dak vaċċinat permezz ta’ test dijanjostiku sabiex jiġu misjuba antikorpi neuraminidase.

influenza virus surface antigens (haemagglutinin and neuraminidase), propagated in eggs, and adjuvanted with mf59c.1, of strain:
sustanzi attivi: antiġeni tal- wiċċ tal- virus ta 'l- influwenza (haemagglutinin u neuraminidase), propagati fil- bajd, u adjuvanti b’ mf59c. 1, tar- razza:

one dose of 0.5 ml contains: influenza virus surface antigens (haemagglutinin and neuraminidase), propagated in eggs, of strain:
doża waħda ta’ 0.5 ml fiha: antiġeni tal-wiċċ tal-virus tal-influwenza (haemagglutinin u neuraminidase), propagati fil-bajd, tar-razza:

if the circulating avian influenza field virus has a different h and/or n component to the h7n1 included in the vaccine, it may be possible to differentiate between vaccinated and infected birds by using a diagnostic test to detect haemagglutinin and/or neuraminidase antibodies.
jekk il-virus tal-influwenza avjarja li qed jiċċirkula fil-beraħ għandu l-komponent h u/jew n tiegħu differenti mill-h7n1, inkluż fil-vaċċin, ikun possibli li tagħraf tagħżel bejn tjur imlaqqma u dawk infettati billi tuża test dijagnostiku li jagħraf il-]aemagglutinin jew/u antikorpi nuraminidejs.